Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Facioscapulohumeral muscular dystrophy.

Tawil R.

Neurotherapeutics. 2008 Oct;5(4):601-6. doi: 10.1016/j.nurt.2008.07.005. Review.

2.

Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?

Richards M, Coppée F, Thomas N, Belayew A, Upadhyaya M.

Hum Genet. 2012 Mar;131(3):325-40. doi: 10.1007/s00439-011-1100-z. Epub 2011 Oct 9. Review.

PMID:
21984394
3.

Facioscapulohumeral dystrophy.

Pandya S, King WM, Tawil R.

Phys Ther. 2008 Jan;88(1):105-13. Epub 2007 Nov 6. Review.

PMID:
17986494
4.

Facioscapulohumeral Muscular Dystrophy.

Statland JM, Tawil R.

Continuum (Minneap Minn). 2016 Dec;22(6, Muscle and Neuromuscular Junction Disorders):1916-1931. Review.

5.

Facioscapulohumeral muscular dystrophy.

van der Maarel SM, Frants RR, Padberg GW.

Biochim Biophys Acta. 2007 Feb;1772(2):186-94. Epub 2006 Jun 6. Review.

6.

Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD).

Zeng W, de Greef JC, Chen YY, Chien R, Kong X, Gregson HC, Winokur ST, Pyle A, Robertson KD, Schmiesing JA, Kimonis VE, Balog J, Frants RR, Ball AR Jr, Lock LF, Donovan PJ, van der Maarel SM, Yokomori K.

PLoS Genet. 2009 Jul;5(7):e1000559. doi: 10.1371/journal.pgen.1000559. Epub 2009 Jul 10.

7.

Facioscapulohumeral muscular dystrophy.

Tawil R, Van Der Maarel SM.

Muscle Nerve. 2006 Jul;34(1):1-15. Review.

PMID:
16508966
8.

Facioscapulohumeral muscular dystrophy.

Statland J, Tawil R.

Neurol Clin. 2014 Aug;32(3):721-8, ix. doi: 10.1016/j.ncl.2014.04.003. Epub 2014 May 15. Review.

9.

Distinguishing the 4qA and 4qB variants is essential for the diagnosis of facioscapulohumeral muscular dystrophy in the Chinese population.

Wang ZQ, Wang N, van der Maarel S, Murong SX, Wu ZY.

Eur J Hum Genet. 2011 Jan;19(1):64-9. doi: 10.1038/ejhg.2010.143. Epub 2010 Aug 25.

10.

Molecular diagnosis of facioscapulohumeral muscular dystrophy.

Upadhyaya M, Cooper DN.

Expert Rev Mol Diagn. 2002 Mar;2(2):160-71. Review.

PMID:
11962336
11.

Recommendations for the management of facioscapulohumeral muscular dystrophy in 2011.

Attarian S, Salort-Campana E, Nguyen K, Behin A, Andoni Urtizberea J.

Rev Neurol (Paris). 2012 Dec;168(12):910-8. doi: 10.1016/j.neurol.2011.11.008. Epub 2012 Apr 30. Review.

PMID:
22551571
12.

[Facioscapulohumeral muscular dystrophy. Clinical picture, atypical forms, diagnostics, genetics].

Jordan B, Müller-Reible C, Zierz S.

Nervenarzt. 2011 Jun;82(6):712-22. doi: 10.1007/s00115-010-2968-x. German.

PMID:
21567298
13.

Facioscapulohumeral muscular dystrophy: consequences of chromatin relaxation.

van der Maarel SM, Miller DG, Tawil R, Filippova GN, Tapscott SJ.

Curr Opin Neurol. 2012 Oct;25(5):614-20. doi: 10.1097/WCO.0b013e328357f22d. Review.

14.

[The possible place of autologus cell therapy in facioscapulohumeral muscular dystrophy].

Desnuelle C, Sacconi S, Marolleau JP, Larghero J, Vilquin JT.

Bull Acad Natl Med. 2005 Apr;189(4):697-713; discussion 713-4. French.

PMID:
16245686
15.

Genetic and epigenetic characteristics of FSHD-associated 4q and 10q D4Z4 that are distinct from non-4q/10q D4Z4 homologs.

Zeng W, Chen YY, Newkirk DA, Wu B, Balog J, Kong X, Ball AR Jr, Zanotti S, Tawil R, Hashimoto N, Mortazavi A, van der Maarel SM, Yokomori K.

Hum Mutat. 2014 Aug;35(8):998-1010. doi: 10.1002/humu.22593. Epub 2014 Jun 24.

16.

Clinical and genetic analysis of Korean patients with facioscapulohumeral muscular dystrophy.

Ki CS, Lee ST, Kim KS, Kim JW, Hong YH, Sung JJ, Park KS, Lee KW.

J Korean Med Sci. 2008 Dec;23(6):959-63. doi: 10.3346/jkms.2008.23.6.959. Epub 2008 Dec 23.

17.

Therapeutic advances in muscular dystrophy.

Leung DG, Wagner KR.

Ann Neurol. 2013 Sep;74(3):404-11. doi: 10.1002/ana.23989. Review.

18.

Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy.

Goto K, Nishino I, Hayashi YK.

Neuromuscul Disord. 2006 Apr;16(4):256-61. Epub 2006 Mar 20.

PMID:
16545566
19.

Facioscapulohumeral Dystrophy.

Wang LH, Tawil R.

Curr Neurol Neurosci Rep. 2016 Jul;16(7):66. doi: 10.1007/s11910-016-0667-0. Review.

PMID:
27215221
20.

[Facioscapulohumeral muscular dystrophy type 2].

Sacconi S, Desnuelle C.

Rev Neurol (Paris). 2013 Aug-Sep;169(8-9):564-72. doi: 10.1016/j.neurol.2013.02.004. Epub 2013 Aug 20. French.

PMID:
23969240

Supplemental Content

Support Center